Contrave brings together two well-known medications—naltrexone and bupropion—to help adults who struggle with obesity or excess weight linked to health problems like high blood pressure or type 2 diabetes. Approved by the FDA in 2014, it targets the brain rather than the stomach or metabolism directly, making it different from many other weight loss options. The goal is steady, sustainable progress when paired with a reduced-calorie diet and regular physical activity.
The combination works by influencing appetite signals and the reward system tied to food. Many people find it easier to resist cravings and feel satisfied with smaller portions, which supports long-term calorie control. Results vary, but clinical studies show an average loss of 5–10% of starting body weight over one year for those who respond well.
Understanding exactly what Contrave does—and what it doesn’t do—helps set realistic expectations and use it safely. This article explains its mechanism, typical effects, who benefits most, and how it compares with similar treatments.
How Contrave Targets the Brain to Reduce Appetite
Contrave acts mainly on two brain regions: the hypothalamus, which regulates hunger and energy balance, and the mesolimbic dopamine pathway, involved in reward and motivation. Bupropion increases dopamine and norepinephrine availability, while naltrexone blocks opioid receptors that normally reinforce pleasurable eating. Together they weaken the drive to overeat and lessen food-related cravings.
Unlike stimulant-based drugs that speed up metabolism, Contrave does not raise heart rate or energy expenditure significantly. Its effect is behavioral—helping people make different choices around food without feeling deprived. This brain-focused approach suits those whose weight struggles involve emotional or habitual eating.
The medication reaches steady levels after consistent dosing, so benefits build gradually over weeks. Appetite suppression often becomes noticeable within the first month, though maximum impact usually requires reaching the full maintenance dose.
What Does Contrave Do
Contrave reduces overall food intake by making meals feel more satisfying and decreasing the pull of high-calorie, highly rewarding foods. In clinical trials, participants taking Contrave ate fewer calories per day on average than those on placebo, without deliberate calorie counting. This natural reduction creates the energy deficit needed for weight loss.
It does not burn fat directly, speed up metabolism, or block nutrient absorption. Instead, it helps the brain register fullness sooner and weakens the emotional reward from overeating. Many users report fewer urges for sweets, snacks between meals, or large portions.
The medication works best when combined with lifestyle changes. On its own, results are modest; with improved eating patterns and movement, the average weight loss in studies reached 5–10% of starting body weight after one year.
Expected Weight Loss Results
In the main COR-I, COR-II, and COR-BMOD trials, people taking Contrave lost an average of 5–9% of their starting weight after 56 weeks, compared with 1–2% on placebo. About one-third achieved at least 10% loss, while roughly one-quarter lost less than 5%.
Higher responders often described stronger control over cravings and easier adherence to reduced portions. Those who continued the medication beyond one year generally maintained most of their loss, provided they kept diet and activity habits in place.
Real-world outcomes mirror trial data for consistent users. Weight loss tends to be gradual—typically 1–2 pounds per month after the initial months—and plateaus are common after significant reduction.
Who Benefits Most from Contrave
Contrave is approved for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol). It suits people whose eating patterns involve frequent cravings, emotional eating, or difficulty feeling full after meals.
Those who have struggled with appetite-focused diets often respond best. The medication helps break the cycle of hunger-driven overeating without requiring extreme restriction. Patients who pair it with structured support—nutrition counseling or behavioral coaching—tend to see stronger, longer-lasting results.
It is not intended for cosmetic weight loss, short-term use, or people without qualifying BMI or comorbidities. A thorough medical evaluation determines suitability.
Common Side Effects and How They Relate to Its Action
The most frequent side effects—nausea, constipation, headache, vomiting, dizziness, insomnia, and dry mouth—stem from bupropion’s effects on the central nervous system and naltrexone’s impact on gut motility. Nausea affects about one-third of users early on but usually improves within weeks.
Because Contrave influences dopamine pathways, some people experience restlessness or mild anxiety, especially during dose increases. These effects are generally mild and temporary. Serious psychiatric events are rare but carry a boxed warning due to bupropion’s known risks.
Gastrointestinal symptoms often lessen when the medication is taken with food and doses are escalated slowly. Staying hydrated and eating fiber-rich foods helps manage constipation.
Comparison of Contrave to Other Weight Loss Medications
Different medications work through distinct mechanisms, leading to varied weight loss patterns and side-effect profiles. Here’s a comparison based on major clinical data:
| Medication | Active Ingredient(s) | Primary Mechanism | Average % Weight Loss (1 Year) | Common Side Effects | Approved For | Key Difference from Contrave |
|---|---|---|---|---|---|---|
| Contrave | Naltrexone + Bupropion | Brain reward & appetite pathways | 5–10% | Nausea, headache, insomnia, constipation | Obesity/overweight + comorbidity | Oral; targets cravings directly |
| Wegovy | Semaglutide | GLP-1 receptor agonist | 13–17% | Nausea, vomiting, diarrhea | Chronic weight management | Injectable; stronger satiety |
| Zepbound | Tirzepatide | GLP-1 + GIP receptor agonist | 15–21% | Nausea, diarrhea, fatigue | Chronic weight management | Dual action; highest average loss |
| Qsymia | Phentermine + Topiramate | Appetite suppression + anticonvulsant | 8–10% | Dry mouth, tingling, insomnia | Chronic weight management | Includes stimulant component |
| Saxenda | Liraglutide | GLP-1 receptor agonist | 5–8% | Nausea, vomiting, constipation | Chronic weight management | Daily injection; lower potency |
Contrave offers a non-injectable option focused on reward and craving pathways, with moderate weight loss compared to newer GLP-1/GIP agents.
Practical Tips for Getting the Most from Contrave
Take the medication exactly as prescribed, starting with one tablet in the morning and gradually increasing to two tablets twice daily. Swallow tablets whole—never crush or chew. Consistency builds steady effects.
Eat balanced, protein-rich meals to stay satisfied and reduce nausea. Drinking plenty of water helps with constipation and overall comfort. Small, frequent meals often work better than large ones.
Track progress beyond the scale—note changes in energy, clothing fit, and craving intensity. Celebrate non-scale victories to stay motivated. Regular check-ins with your provider allow dose adjustments if needed.
Summary
Contrave reduces appetite and food cravings by acting on brain reward and hunger centers, helping eligible adults achieve 5–10% average weight loss over one year when combined with lifestyle changes. It does not speed metabolism, block fat absorption, or treat depression—its primary role is supporting long-term calorie control through reduced urges and earlier fullness.
The medication suits people whose weight challenges involve frequent cravings or emotional eating patterns. Side effects are mostly mild and manageable, though psychiatric monitoring remains important due to bupropion’s profile. Compared with newer injectable options, Contrave provides moderate results with the convenience of an oral tablet.
FAQ
What is the main way Contrave helps people lose weight?
Contrave reduces appetite and weakens the reward response to food by acting on brain pathways. This leads to naturally lower calorie intake without extreme restriction. Most users find it easier to choose smaller portions and resist cravings.
Does Contrave speed up metabolism or burn fat directly?
No, Contrave does not increase metabolic rate or block fat absorption. Its effect is behavioral—helping control how much and what you eat. Weight loss occurs because of the resulting calorie deficit.
How soon do people usually notice appetite changes on Contrave?
Many report reduced hunger or fewer cravings within the first 2–4 weeks. Full effects often strengthen after reaching the maintenance dose of two tablets twice daily. Progress builds gradually over months.
Is Contrave approved to treat depression or mood disorders?
No, Contrave is approved only for chronic weight management. It is not indicated for depression, even though one ingredient (bupropion) treats depression in different formulations. It carries warnings for potential mood-related risks.
Who is Contrave typically prescribed for?
It is approved for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition (e.g., hypertension, type 2 diabetes). Candidates should have tried diet and exercise first.
How does Contrave compare with GLP-1 medications like Wegovy or Zepbound?
Contrave is oral and targets brain reward pathways, with average losses of 5–10%. GLP-1/GIP drugs like Zepbound produce higher average losses (15–21%) through stronger satiety but require injections. Choice depends on preference and medical suitability.
What should I do if I don’t feel any appetite reduction on Contrave?
Check adherence to the full dose schedule and discuss with your provider. Some people need time at maintenance strength or lifestyle tweaks to notice effects. If no benefit occurs after 12–16 weeks at full dose, reevaluation is recommended.
Dr. Hamza is a medical content reviewer with over 12+ years of experience in healthcare research and patient education. He specializes in evidence-based health information, medications, and chronic conditions. His reviews are grounded in trusted medical sources and current clinical guidelines to ensure accuracy, transparency, and reliability. Content reviewed by Dr. Hamza is intended for educational purposes and is not a substitute for professional medical advice.